MX2016017081A - Tratamiento de hipertrigliceridemia grave. - Google Patents
Tratamiento de hipertrigliceridemia grave.Info
- Publication number
- MX2016017081A MX2016017081A MX2016017081A MX2016017081A MX2016017081A MX 2016017081 A MX2016017081 A MX 2016017081A MX 2016017081 A MX2016017081 A MX 2016017081A MX 2016017081 A MX2016017081 A MX 2016017081A MX 2016017081 A MX2016017081 A MX 2016017081A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- severe hypertriglyceridemia
- mbx
- type
- hypertriglyceridemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462017444P | 2014-06-26 | 2014-06-26 | |
| PCT/US2015/037596 WO2015200580A1 (en) | 2014-06-26 | 2015-06-25 | Treatment of severe hypertriglyceridemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016017081A true MX2016017081A (es) | 2017-05-01 |
Family
ID=53511030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016017081A MX2016017081A (es) | 2014-06-26 | 2015-06-25 | Tratamiento de hipertrigliceridemia grave. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150374649A1 (enExample) |
| EP (1) | EP3160458A1 (enExample) |
| JP (1) | JP2017519028A (enExample) |
| KR (1) | KR20170020514A (enExample) |
| CN (1) | CN106470675A (enExample) |
| AU (1) | AU2015279905A1 (enExample) |
| BR (1) | BR112016028918A2 (enExample) |
| CA (1) | CA2951280A1 (enExample) |
| CL (1) | CL2016003290A1 (enExample) |
| EA (1) | EA201790091A1 (enExample) |
| HK (1) | HK1231380A1 (enExample) |
| IL (1) | IL249757A0 (enExample) |
| MX (1) | MX2016017081A (enExample) |
| PH (1) | PH12016502415A1 (enExample) |
| SG (1) | SG11201610243YA (enExample) |
| WO (1) | WO2015200580A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| ES2701094T3 (es) | 2014-03-20 | 2019-02-20 | Cymabay Therapeutics Inc | Tratamiento de enfermedades colestáticas intrahepáticas |
| CA2944139C (en) | 2014-04-11 | 2020-11-03 | Cymabay Therapeutics, Inc. | Treatment of nafld and nash |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| CA3085951C (en) * | 2017-12-21 | 2022-10-11 | Kowa Company, Ltd. | Methods of treatment of hypertriglyceridemia |
| US20210145774A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Treatment of alcoholic liver disease |
| WO2021097034A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Seladelpar for use in the treatment of intestinal barrier dysfunction and associated diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA87467C2 (xx) | 2003-09-19 | 2009-07-27 | Янссен Фармацевтика Н.В | 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| SG183529A1 (en) * | 2010-03-30 | 2012-10-30 | Novartis Ag | Uses of dgat1 inhibitors |
-
2015
- 2015-06-25 CN CN201580033722.XA patent/CN106470675A/zh active Pending
- 2015-06-25 EA EA201790091A patent/EA201790091A1/ru unknown
- 2015-06-25 KR KR1020177002016A patent/KR20170020514A/ko not_active Withdrawn
- 2015-06-25 US US14/749,934 patent/US20150374649A1/en not_active Abandoned
- 2015-06-25 JP JP2016575073A patent/JP2017519028A/ja not_active Withdrawn
- 2015-06-25 EP EP15734013.4A patent/EP3160458A1/en not_active Withdrawn
- 2015-06-25 BR BR112016028918A patent/BR112016028918A2/pt not_active Application Discontinuation
- 2015-06-25 CA CA2951280A patent/CA2951280A1/en not_active Abandoned
- 2015-06-25 WO PCT/US2015/037596 patent/WO2015200580A1/en not_active Ceased
- 2015-06-25 SG SG11201610243YA patent/SG11201610243YA/en unknown
- 2015-06-25 HK HK17105013.3A patent/HK1231380A1/zh unknown
- 2015-06-25 MX MX2016017081A patent/MX2016017081A/es unknown
- 2015-06-25 AU AU2015279905A patent/AU2015279905A1/en not_active Abandoned
-
2016
- 2016-12-02 PH PH12016502415A patent/PH12016502415A1/en unknown
- 2016-12-22 CL CL2016003290A patent/CL2016003290A1/es unknown
- 2016-12-25 IL IL249757A patent/IL249757A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2016003290A1 (es) | 2017-09-08 |
| PH12016502415A1 (en) | 2017-02-27 |
| EP3160458A1 (en) | 2017-05-03 |
| SG11201610243YA (en) | 2017-01-27 |
| IL249757A0 (en) | 2017-02-28 |
| EA201790091A1 (ru) | 2017-07-31 |
| CN106470675A (zh) | 2017-03-01 |
| WO2015200580A1 (en) | 2015-12-30 |
| BR112016028918A2 (pt) | 2017-08-22 |
| AU2015279905A1 (en) | 2017-02-02 |
| JP2017519028A (ja) | 2017-07-13 |
| KR20170020514A (ko) | 2017-02-22 |
| CA2951280A1 (en) | 2015-12-30 |
| US20150374649A1 (en) | 2015-12-31 |
| HK1231380A1 (zh) | 2017-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278150A (en) | A transgenic bacterium for the treatment of diseases related to hyperammonemia | |
| EP3527125C0 (en) | CATHETER WITH HIGH DENSITY ELECTRODE TIP ARRAY | |
| HUE040315T2 (hu) | Beültethetõ elektróda elrendezés | |
| CL2016002971A1 (es) | Combinación. | |
| ZA201703779B (en) | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies | |
| MA43968A (fr) | Thérapie génique pour traiter la mucopolysaccharidose de type i | |
| DK3162402T3 (da) | Næsespraydyse til anvendelse i medicinsk sprøjte | |
| IL260684B (en) | Treatment for modulating gut microbiota | |
| SI3104854T1 (sl) | Stabilizatorji mastocitov za zdravljenje pljučnih bolezni | |
| PH12016502415A1 (en) | Treatment of severe hypertriglyceridemia | |
| IL243044B (en) | Far field-insensitive intracardiac catheter electrodes | |
| DK3229840T3 (da) | 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne | |
| SG10202013095YA (en) | Methods to improve cell therapy | |
| AU363946S (en) | Catheter gripper aid | |
| MX2016012203A (es) | Tratamiento de enfermedades colestasicas intrahepaticas. | |
| DK3125874T3 (da) | Et terapeutisk middel til anvendelse i behandlingen af infektioner | |
| HUE046894T2 (hu) | Anamorelinen alapuló gyógyászati kezelések | |
| MA47847A (fr) | Thérapie génique pour traiter la mucopolysaccharidose de type i | |
| IL246052B (en) | Biomedical electrode having low oxygen content | |
| LT3229790T (lt) | Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme | |
| MA41171A (fr) | Acides pyridyl-cycloalkyl-carboxylic substitués, compositions les contenant et leurs utilisations médicales | |
| PT3188778T (pt) | Injetor tipo caneta | |
| DK3230215T3 (da) | Afvandningsoptimering i realtid | |
| PH12016502311A1 (en) | Omega-3 analogues | |
| EP3194030A4 (en) | Substituted phenylpyrrolecarboxamides with therapeutic activity in hiv |